Skip to main content
Fig. 1 | Cancer Cell International

Fig. 1

From: HOPX is a tumor-suppressive biomarker that corresponds to T cell infiltration in skin cutaneous melanoma

Fig. 1

HOPX has diagnostic and prognostic value in SKCM patients. (A) Expression of HOPX in paracancer and tumor tissues in TCGA (The Cancer Genome Atlas) database. (B) HOPX is expressed at low levels in SKCM patients according to the TCGA database. (C-F) The GEO (Gene Expression Omnibus) database verified that HOPX is expressed at low levels in SKCM patients. (G) Expression of HOPX in skin sections of normal controls and melanoma patients (HPA030180). (H) The ROC (receiver-operating characteristic) curve showed the high-expression specificity of HOPX in SKCM patients in TCGA. AUC, area under the curve. (I) KM (Kaplan‒Meier) curve showed the better overall survival in SKCM patients with high HOPX expression in TCGA. (J) Nomogram predicting 1-, 5-, and 10-year survival rates for SKCM patients based on HOPX expression

Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us